The influence of the haptoglobin phenotype on the concentration of specific markers (sCD163, IL-10, HMGB1 and p53) regulating inflammatory processes in the body in patients with type 2 diabetes was determined. This evidence concerns the gene HMGB1 and type 2 diabetes mellitus.